Tidal Trust II - Defiance Daily Target 2X Long HIMS ETF
U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...
UNILAD13h
Man claims his 'genitals shrank and changed shape' after taking notable hair loss drug
A man has claimed his genitals 'shrank and changed shape' after taking a hair loss drug. According to the Wall Street Journal ...
Scot Scoop News17h
Satire: Gambling it all on unapproved weight-loss drugs
Step right up, ladies and gentlemen, and welcome to the hottest new spot in town: The Weight-Loss Casino! Here, you don’t ...
These 20 stocks are likely to be losers no matter what the market does
The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...
Army vet, 26, says his genitals shrank, changed shape after taking popular hair loss drug
Former US Army Sgt. Mark Millich’s sex drive plummeted — and his genitals shrank and changed shape after taking popular hair-loss drug finasteride.
Queerty1d
Gen Z men are the biggest beauty market no one’s talking about
They spend (far) more time fussing with their hair than women.
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
ConsumerAffairs1d
Hair loss your biggest problem? Try finasteride and you may have a worse problem
Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking ...
Hims & Hers (HIMS) Investors Pulling Their Hair Out Over Pills Side-Effects
Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...
Zacks Investment Research on MSN1d
Hims & Hers Stock Gains 8.6% in Three Months: How to Play It?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.